Holen Sie sich die Stockscreener-App
26.97
2.92%
-0.81
Handel nachbörslich:
26.97
Schlusskurs vom Vortag:
$27.78
Offen:
$27.51
24-Stunden-Volumen:
144.12K
Relative Volume:
0.80
Marktkapitalisierung:
$514.96M
Einnahmen:
$861.97M
Nettoeinkommen (Verlust:
$54.34M
KGV:
9.53
EPS:
2.83
Netto-Cashflow:
$65.64M
1W Leistung:
-0.99%
1M Leistung:
-8.85%
6M Leistung:
-28.88%
1J Leistung:
-44.39%
1-Tages-Spanne:
$26.95
$27.73
1-Wochen-Bereich:
$26.19
$28.18
52-Wochen-Spanne:
$26.19
$49.78
Usana Health Sciences Inc Stock (USNA) Company Profile
Firmenname
Usana Health Sciences Inc
Sektor
Branche
Telefon
(801) 954-7100
Adresse
3838 WEST PARKWAY BLVD., SALT LAKE CITY, UT
Vergleichen Sie USNA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
USNA
Usana Health Sciences Inc
|
26.97 | 514.96M | 861.97M | 54.34M | 65.64M | 2.83 |
|
KHC
Kraft Heinz Co
|
30.43 | 37.02B | 25.85B | 2.74B | 3.02B | 2.26 |
|
GIS
General Mills Inc
|
59.79 | 32.67B | 19.64B | 2.56B | 2.48B | 4.55 |
|
K
Kellanova
|
82.49 | 28.11B | 12.75B | 1.34B | 1.13B | 3.87 |
|
MKC
Mccormick Co Inc
|
82.31 | 21.89B | 6.68B | 792.60M | 774.40M | 2.94 |
|
HRL
Hormel Foods Corp
|
30.94 | 16.67B | 11.92B | 805.04M | 1.01B | 1.46 |
Usana Health Sciences Inc Stock (USNA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-06-23 | Eingeleitet | Sidoti | Buy |
| 2022-07-07 | Herabstufung | Jefferies | Hold → Underperform |
| 2022-04-14 | Eingeleitet | DA Davidson | Neutral |
| 2020-12-17 | Eingeleitet | ROTH Capital | Buy |
| 2019-08-22 | Eingeleitet | Jefferies | Hold |
| 2019-04-16 | Eingeleitet | Tigress Financial | Buy |
| 2018-10-25 | Hochstufung | Sidoti | Neutral → Buy |
| 2018-10-24 | Hochstufung | Pivotal Research Group | Hold → Buy |
| 2018-04-23 | Herabstufung | Pivotal Research Group | Buy → Hold |
| 2018-02-07 | Bestätigt | Pivotal Research Group | Buy |
| 2018-01-24 | Herabstufung | Sidoti | Buy → Neutral |
| 2017-10-25 | Bestätigt | Pivotal Research Group | Buy |
| 2017-07-26 | Bestätigt | Pivotal Research Group | Buy |
| 2017-05-03 | Hochstufung | Pivotal Research Group | Hold → Buy |
| 2017-05-01 | Herabstufung | Pivotal Research Group | Buy → Hold |
| 2017-02-08 | Bestätigt | Pivotal Research Group | Buy |
| 2016-07-28 | Bestätigt | DA Davidson | Neutral |
| 2016-02-10 | Herabstufung | DA Davidson | Buy → Neutral |
| 2015-10-16 | Hochstufung | Sidoti | Neutral → Buy |
| 2015-09-16 | Hochstufung | DA Davidson | Neutral → Buy |
| 2015-08-06 | Herabstufung | DA Davidson | Buy → Neutral |
| 2015-08-05 | Hochstufung | Pivotal Research Group | Hold → Buy |
| 2015-06-26 | Eingeleitet | DA Davidson | Buy |
Alle ansehen
Usana Health Sciences Inc Aktie (USNA) Neueste Nachrichten
Personal Care Stocks Q4 Teardown: USANA (NYSE:USNA) Vs The Rest - The Globe and Mail
Usana Health Sciences Inc (USNA) Shares Up 3.67% on Mar 26 - GuruFocus
USANA stock touches 52-week low at $26.75 amid market challenges - Investing.com Australia
USANA stock touches 52-week low at $26.75 amid market challenges By Investing.com - Investing.com South Africa
At US$27.31, Is It Time To Put USANA Health Sciences, Inc. (NYSE:USNA) On Your Watch List? - Yahoo Finance
USANA Health Sciences Faces Market Risk with Uncertain Hiya Acquisition Benefits - TipRanks
USANA at Sidoti Small-Cap Conference: Strategic Growth and Hiya Acquisition - Investing.com Canada
USANA names Dr. Kathryn Armstrong as new chief scientific officer - MSN
USANA stock touches 52-week low at $27.58 amid market challenges By Investing.com - Investing.com South Africa
USANA stock touches 52-week low at $27.58 amid market challenges - Investing.com Australia
Usana Health Sciences chief legal officer sells $186,513 in stock By Investing.com - Investing.com Australia
Usana Health Sciences chief legal officer sells $186,513 in stock - Investing.com India
Usana Health Sciences chief commercial officer sells $153,387 in stock - Investing.com
Usana Health Sciences chief commercial officer sells $153,387 in stock By Investing.com - Investing.com UK
Usana Health Sciences director John Turman sells $16,647 in stock By Investing.com - Investing.com Australia
USANA HEALTH SCIENCES INC SEC 10-K Report - TradingView
Usana Health Sciences director John Turman sells $16,647 in stock - Investing.com India
Usana Health Sciences chief sales officer sells $106,669 in stock By Investing.com - Investing.com Australia
Usana Health Sciences chief sales officer sells $106,669 in stock - Investing.com
USANA MLM top earners 2024 | The impact and result - Epixel MLM Software
Usana health sciences director sells common stock for $21,190 - Investing.com India
Usana health sciences director sells common stock for $21,190 By Investing.com - Investing.com South Africa
USANA Health Sciences, Inc. (NYSE:USNA) Shares Bought by Principal Financial Group Inc. - Defense World
USANA Health Sciences, Inc. (NYSE:USNA) Holdings Raised by Rhumbline Advisers - Defense World
Usana Health Sciences reports revenue slide, but says non-MLM acquisition will drive new growth - SupplySide Supplement Journal
Usana Health Sciences CEO sells shares worth $147,350 By Investing.com - Investing.com Australia
Usana Health Sciences CEO sells shares worth $147,350 - Investing.com India
Usana Health Sciences director Peggie Pelosi sells $21,918 in stock By Investing.com - Investing.com Australia
Usana Health Sciences director Peggie Pelosi sells $21,918 in stock - Investing.com India
USANA Exec. Chairman Kevin Guest Invites All to Celebrate March's Listening Awareness Month - Financial Times
SHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against USANA Health Sciences, Inc. and Encourages Investors with Losses to Contact the Firm - ACCESS Newswire
Q3 EPS Forecast for USANA Health Sciences Lifted by Analyst - MarketBeat
DA Davidson Issues Pessimistic Estimate for USNA Earnings - MarketBeat
USANA : joint-support supplement earns third seal of approval -September 15, 2021 at 09:24 am EDT - Marketscreener.com
Brokers Set Expectations for USNA Q1 Earnings - MarketBeat
Sidoti Csr Issues Positive Outlook for USNA Earnings - Defense World
USANA Health Sciences (NYSE:USNA) Releases Quarterly Earnings Results, Beats Estimates By $0.15 EPS - MarketBeat
DA Davidson Has Negative Outlook for USNA Q1 Earnings - Defense World
USANA Health Sciences (NYSE:USNA) Issues FY 2025 Earnings Guidance - MarketBeat
USANA Health Sciences (NYSE:USNA) Shares Gap Up Following Better-Than-Expected Earnings - MarketBeat
USANA Health Sciences (NYSE:USNA) Sets New 12-Month Low on Analyst Downgrade - MarketBeat
DA Davidson Has Lowered Expectations for USANA Health Sciences (NYSE:USNA) Stock Price - MarketBeat
Sidoti Csr Issues Pessimistic Estimate for USNA Earnings - Defense World
USANA Health Sciences (NYSE:USNA) Trading 3.4% HigherTime to Buy? - MarketBeat
USANA Health Sciences Earnings Call Highlights Growth and Strategic Moves - TipRanks
USANA Health Sciences stock tumbles following tepid FY2025 guidance By Investing.com - Investing.com Canada
USANA Health Sciences stock tumbles following tepid FY2025 guidance - Investing.com
Finanzdaten der Usana Health Sciences Inc-Aktie (USNA)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.38%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):